Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
■ INTRODUCTION
Crystallization, as an important separation and purification
promote the crystallization of a dimer-based crystal. A similar
link has also been found in 5-fluorouracil4 and tolbutamide.5
operation, is widely used in the chemical industry such as However, this link is not applicable for all substances, such as
pharmaceuticals, food, and agriculture. Nucleation is the key mandelic acid.6
step in the crystallization process and has an important Molecular computational model is a useful tool to
influence on the polymorphism and particle size distribution.1 investigate the mechanism of nucleation at the molecular
However, the understanding of nucleation is still insufficient scale. In several papers reported by Rasmuson and co-
since nucleation is sensitive to experimental conditions and workers,7−10 a DFT computational model of the first solvation
difficult to observe directly. shell and the 1:1 solute−solvent specific site binding energy
Solvent generally has an important influence on crystal was used to study the nucleation behavior of solutes in
nucleation involving the crystal polymorph and the nucleation different solvents. In general, the influence of solvent on
rate.2 The link between solution chemistry and crystal nucleation is mainly dependent on solute−solvent interac-
structure has become a hot issue in polymorphism research. tions. 7−9 However, In the recently published article,
In certain systems, it has been confirmed that there exists a Zeglinski10 found that the solvent effect on the nucleation of
clear link between the growth synthon formed in solution and tolbutamide exists not only in the difference of solute−solvent
the structural synthon packed in the crystal. Through interactions but also in the formation of various conformations
molecular dynamics simulations, Chen3 found that strong and species of the solute molecular in different solvents.
interactions between tetrolic acid (TTA) and solvent Lynch11 successfully predicted nucleation of isonicotinamide
molecules (ethanol or dioxane) prevent the formation of in seven different organic solvents by the DFT computed
carboxylic acid dimers in solution and thus promote the solvent−solute interactions in the absence of nucleation
crystallization of TTA in a catemer-based form or a solvate
form. While weak interactions between TTA and solvent Received: October 19, 2018
molecules (carbon tetrachloride or chloroform) facilitate the Revised: January 27, 2019
formation of carboxylic acid dimers in solution and thus Published: February 6, 2019
induction time experimental data. Besides, solution spectros- (the stick model highlighted in the Figure 2) which constructs
copy methods (such as IR,7−10 Raman,7 NMR12,13) are the crystal structure as an asymmetric unit.
frequently used to explore the link between solution chemistry In this study, we obtained the nucleation kinetic data of ETR
and certain macroscopic processes in crystallization. In the in four different solvents through the induction time
work of Rasmuson and co-workers,7−10 the infrared spectrum measurement experiments. Solute−solvent interactions were
was used as a probe of the solute−solvent interaction to investigated by infrared spectroscopy, molecular computational
explain the solvent effect on nucleation, and the carbonyl models, and crystal structure analysis. Finally, we propose a
frequency shift in the solution spectrum increases as the mechanism for the solvent effect on ETR nucleation.
■
solute−solvent interaction increases.
Etoricoxib (ETR) is a selective cyclooxygenase-2 (COX-2) MATERIALS AND METHODS
inhibitor for the treatment of osteoarthritis, rheumatoid
arthritis, and acute gouty arthritis.14,15 ETR is a medium- Materials. Etoricoxib (>99%), form III, was purchased from
Wuhan Hongruikang Reagent Co., Ltd., and used without further
sized (358.84 g mol−1) molecule with conformational purification. Form I was prepared by rapid cooling in acetone. All
flexibility. The molecular structure of ETR is shown in Figure solvents (toluene, acetone, acetonitrile, and ethanol) were of
1. Five polymorphs (forms I−V) and two hydrates16−18 of analytical reagent and were purchased from Tianjin Kemiou Chemical
Reagent Co., Ltd.
Solubility Measurement. Solubility data for ETR form I was
measured in this work for each solvent at 10 °C using a laser
monitoring dynamic method. Detailed solubility measurement
methods are recorded in the Supporting Information.
Induction Time Measurement. Nucleation rates were calculated
from induction time distributions using the probability method.20
Although the precise saturation temperatures (Tsat) for the solutions
were not known, previous solubility measurements18 indicated all Tsat
were less than 40 °C for the range of solutions employed.
Stock solutions were prepared in a 100 mL sealed conical flask in a
water bath by weighing appropriate amounts of ETR form I and
solvent according to our solubility data at 10 °C. An equilibration
period at 50 °C was allowed overnight, with agitation provided with a
PTFE (polytetrafluoroethylene) coated magnetic stirrer at 500 rpm.
Figure 1. Molecular structure of ETR. Solutions were dispensed via preheated syringes and 0.2 mm PTFE
filters, into sixteen 10 mL glass vials. A magnetic stirring bar was
added to each vial prior to sealing with a plastic screw cap with a
ETR have been reported so far. Form I and form V are PTFE seal. Solutions were then subjected to a second equilibration
enantiotropic and form V is more stable at room temper- period at 50 °C overnight before the crystallization experiments were
ature.19 In the present work, only form I was recorded in the performed.
induction time measurement experiments; therefore, the Then, solutions were transferred from bath A at 50 °C to bath B
polymorphism phenomenon was not taken into account in held at 10 °C to obtain supersaturation. Agitation was provided at 500
the solvent effect. The crystal structure of ETR form I was rpm via a magnetic stirrer under the water bath. The induction time
determined by Grobelny18 in 2011, and Figure 2 shows its was measured as the difference between the time when the solution
becomes cloudy and the time when the vials were transferred to bath
B. Once all vials had nucleated, they were transferred back to water
bath A where complete dissolution occurred. Before performing the
next nucleation experiment, all the solutions were dissolved
completely and kept at this state for 1 h to ensure equilibrium.
This cycle was repeated five times, giving a maximum total of 80
induction time measurements at each chosen supersaturation.
Solid samples were isolated by filtration, and the crystal form was
determined by PXRD. In all cases, the solid phase was pure ETR form
I. PXRD patterns of crystals obtained in different solvents are shown
in Figure S1 in the Supporting Information.
It is worth mentioning that ETR exhibits burst nucleation in all
cases of the induction time measurement experiments. Around 30 s
elapsed between the first detection of faint cloudiness in the solution
and the apparent end point of crystallization, at which stage the
solutions were white slurries. Subsequently, the crystal was quickly
sucked out with a pipet to measure the crystal morphology with a
microscope.
Figure 2. Molecular packing along the ac plane in the crystal structure
Computational Methods. Solute−Solvent Interactions. Sol-
of the ETR form I. H-bonds shown as dotted lines.
ute−solvent interactions were captured by DFT 1:1 solute−solvent
binding energies and molecular dynamics (MD) computed solute−
bulk solvent interaction energies with a solvation model.
molecular arrangement. Despite the absence of strong
The crystal structure of ETR form I was directly obtained from the
hydrogen bonds due to the lack of hydrogen bond donor in Cambridge Structural Database (855682), and then the ETR
the ETR molecule, weak hydrogen bonds are possible and are molecule was extracted from the ETR form I crystal.
seen in the form of C−H···OS hydrogen bonds. The MD Calculation. MD calculations of solute−bulk solvent
sulfonyl accepts hydrogen bonds from the activated C-H interaction energies were performed by the Materials Studio
groups in the molecule and forms a sulfonyl dimer synthon package.21 The details are recorded in the Supporting Information.
DFT Calculations. Density functional theory (DFT) calculations Table 1. Comparison of the Solubility of ETR Form I at 10
were performed using the Gaussian 09 package.22 The four solvents °C Measured in This Work and Reported in Literature
used in our experiment represent different polarity and H-bond
capability. Ethanol is both a H-bond donor and acceptor, acetone and solvent measured mole fraction literature mole fraction
acetonitrile are only H-bond acceptors, while toluene is not capable of toluene 0.0113
making strong H-bonds, although it can interact through π−π acetone 0.0343 0.0336
stacking. The (1:1) solute−solvent binding energies are probed at
ethanol 0.00312 0.00306
seven sites of the ETR molecule with the aid of the electrostatic
potential map (EPM) as shown in Figure 3. The EPM is related to the acetonitrile 0.0191 0.0157
■ RESULTS
Solubility. Table 1 gives the saturation concentration of
relationship of ETR in the other three solvents. Thus, the
steady-state nucleation rate J can be determined for the range
of solutions employed.
ETR form I in the four solvents at 10 °C. Reference values According to the classical nucleation theory, the nucleation
ij −16πγ 3Vs2 1 yz
rate can be written as follows
taken from the literature19 are also included, and there is no
J = A expjjj zz
j 3k 3T 3 ln 2 S zz
report on the solubility of ETR in toluene.
k {
Nucleation Rate. Jiang and ter Horst20 proposed that the
probability of detection of a crystal nucleus in time t at small B (3)
Figure 8. RDFs between the O atom on the ETR molecule and the H
atoms on four different solvent molecules.
■
7-8
2 notes:
DISCUSSION
ETR form I is a kinetic dominant crystal form that crystallizes
in the manner of burst nucleation in all cases of the induction
time measurement experiments in this study. The crystal
morphology of ETR form I obtained after burst nucleation in
different solvents is shown in Figure 12. Regardless of the
the a-axis, the two oxygen atoms of the sulfonyl interact with solvent interaction, and as a result, this shift was highly
the hydrogen atom of the methyl group of an adjacent ETR correlated with the binding energy calculated by DFT. The
molecule and the hydrogen atom of the pyridine ring of combined solution infrared spectrum and DFT binding energy
another adjacent ETR molecule through C−H···O weak calculation successfully capture the solute−solvent interaction.
hydrogen bonds, respectively, forming an ETR molecular Figure 14 shows the relationship between the stretching
chain with the sulfonyl dimer as basic unit. In addition, along vibration frequency of sulfonyl and the binding energy at site 1.
the c-axis direction, an oxygen atom of the sulfonyl participates
in the connection between the ETR chains. It is evident that
sulfonyl plays an important role in the construction of the
crystal structure of ETR form I. The combination of solvent on
the sulfonyl retards the nucleation of ETR.
The results of nucleation induction time measurement
experiments show that crystal nucleation of ETR in different
solvents becomes increasingly more difficult in the order:
toluene < acetone < acetonitrile < ethanol. Nucleation kinetic
parameter interfacial energies were further derived according
to the classical nucleation theory, which increase in the same
order as the nucleation difficulty in different solvents.
Interaction energies between a solute and different bulk
solvents from MD simulation have a certain deviation from the
difficulty of nucleation. The ETR molecule can interact with
the solvent molecule at multiple sites due to its relatively large
size and complex structure. Seven sites representing all the
important binding features of the ETR molecule were selected
to calculate 1:1 solute−solvent binding energies. The strength Figure 14. Relationship between the stretching vibration frequency of
sulfonyl and the binding energy at site 1.
of solute−solvent binding energies at site 1 is highly correlated
with the nucleation rate. Figure 13 shows the relationship
between the supersaturation required to reach the same
nucleation rate of 200 m−3 s−1 and the binding energy at site 1. Therefore, the rate-determining step of ETR nucleation is
the desolvation of sulfonyl, and the nucleation process of ETR
is exactly determined by the interaction between the specific
sulfonyl and the solvent. The stronger the solvent binds to the
sulfonyl on the ETR molecule, the more energy is needed to
remove the solvent bonded to the sulfonyl during nucleation,
and the slower the nucleation rate becomes.
■ CONCLUSION
Previous research on ETR crystallization focused mainly on
polymorphs and co-crystal, while its nucleation kinetics have
been rarely studied to date. We sought to reveal the nucleation
mechanism of ETR through investigating the effect of solute−
solvent interaction on the crystallization behavior of ETR in
different solvents. The infrared spectral shift of the sulfonyl
group was used to characterize the solute−solvent interaction,
which increases in the order: toluene < acetone < acetonitrile <
ethanol, and this order is consistent with the nucleation
difficulty order. Computational models were also used to study
Figure 13. Relationship between the supersaturation required to solute−solvent interactions. The strength of DFT solute−
reach the same nucleation rate of 200 m−3 s−1 and the binding energy solvent binding energies at site 1 is highly correlated with the
at site 1. infrared spectral shift of the sulfonyl. The step of limiting the
formation of the ETR nucleus is the molecular arrangement
Carbonyl serves as a shared functional group of model drugs along the ac plane, and the sulfonyl plays an important role in
in several studies of Rasmuson and co-workers,7−10 and the the construction of the crystal structure of ETR form I as the
stretching vibration band shift of it was selected as a probe to hydrogen bond acceptor. The combined method of infrared
study the strength of the solute−solvent interactions. spectral, DFT calculation, and crystal structure analysis does
Generally, the stronger the solvent interacts with carbonyl, capture the binding strength of solvent molecules to the
the lower the frequency it absorbs. However, in the present sulfonyl on the ETR molecule. It can be concluded that the
study, the carbonyl is not included in the ETR molecule rate-determining step of ETR nucleation is the desolvation of
structure. Comparing the solution infrared spectrum of sulfonyls, and the solvent effect on nucleation of ETR is
different solvents, it can be found that the asymmetric specifically determined by the interaction between the sulfonyl
stretching vibration band of the sulfonyl shows significant and the solvent. The stronger the solvent binds to the sulfonyl
differences. Therefore, in this study, the shift of the stretching group on the ETR molecule, the slower the nucleation
vibration band of sulfonyl was used to characterize the solute− becomes.
1666 DOI: 10.1021/acs.cgd.8b01571
Cryst. Growth Des. 2019, 19, 1660−1667
Crystal Growth & Design
■
Article
ASSOCIATED CONTENT (9) Mealey, D.; Zeglinski, J.; Khamar, D.; Rasmuson, Å. C. Influence
of Solvent on Crystal Nucleation of Risperidone. Faraday Discuss.
*
S Supporting Information
2015, 179, 309−328.
The Supporting Information is available free of charge on the (10) Zeglinski, J.; Kuhs, M.; Khamar, D.; Hegarty, A. C.; Devi, R. K.;
ACS Publications website at DOI: 10.1021/acs.cgd.8b01571. Rasmuson, Å. C. Crystal Nucleation of Tolbutamide in Solution:
Solubility measurements details and computational Relationship to Solvent, Solute Conformation, and Solution Structure.
Chem. - Eur. J. 2018, 24, 4916−4926.
methods. Figure S1: PXRD patterns of ETR form I.
(11) Lynch, M. B.; Lawrence, S. E.; Nolan, M. Predicting Nucleation
Figures S2−S4: Induction time distributions of ETR in of Isonicotinamide from the Solvent-Solute Interactions of
toluene, acetonitrile, and ethanol at 10 °C, respectively. Isonicotinamide in Common Organic Solvents. J. Phys. Chem. A
Figures S5−S7: Relationship between induction time 2018, 122, 3301−3312.
and cumulative probability according to eq 2 of ETR in (12) Tang, W. W.; Mo, H. P.; Zhang, M. T.; Gong, J. B.; Wang, J. K.;
toluene, acetonitrile, and ethanol at 10 °C, respectively. Li, T. L. Glycine’s pH-Dependent Polymorphism: A Perspective from
Figures S8−S10: Solution IR spectroscopy at different Self-Association in Solution. Cryst. Growth Des. 2017, 17, 5028−5033.
concentrations of ETR in toluene, acetonitrile, and (13) Tang, W. W.; Mo, H. P.; Zhang, M. T.; Parkin, S.; Gong, J. B.;
ethanol, respectively. Figure S11: The computed Wang, J. K.; Li, T. L. Persistent Self-Association of Solute Molecules
morphology in vacuum of ETR form I (PDF) in Solution. J. Phys. Chem. B 2017, 121, 10118−10124.
(14) Mittapalli, S.; Bolla, G.; Perumalla, S.; Nangia, A. Can We
■ AUTHOR INFORMATION
Corresponding Author
Exchange Water in a Hydrate Structure: A Case Study of Etoricoxib.
CrystEngComm 2016, 18, 2825−2829.
(15) Bickham, K.; Kivitz, A. J.; Mehta, A.; Frontera, N.; Shah, S.;
Stryszak, P.; Popmihajlov, Z.; Peloso, P. M. Evaluation of Two Doses
*Phone: +86-13820852735. Fax: +86-27405754. E-mail: of Etoricoxib, A COX-2 Selective Non-steroidal Anti-inflammatory
yingbao@tju.edu.cn. Drug (NSAID), in the Treatment of Rheumatoid Arthritis in a
ORCID Double-blind, Randomized Controlled Trial. BMC Musculoskeletal
Ying Bao: 0000-0002-4461-8035 Disord. 2016, 17, 331.
(16) Clas, S. D.; Dalton, C.; Crocker, L. S.; McCauley, J. A.; Davis, I.
Notes U.S. Patent US6,441,002, 2002.
The authors declare no competing financial interest. (17) Crocker, L. S.; Davis, I. W.; Richard, R. G.; Kotliar, A. Patent
■ ACKNOWLEDGMENTS
The authors are grateful for the financial support of the
WO02/096877A1, 2002.
(18) Grobelny, P.; Mukherjee, A.; Desiraju, G. R. Polymorphs and
Hydrates of Etoricoxib, A Selective COX-2 Inhibitor. CrystEngComm
2012, 14, 5785−5794.
National Natural Science Foundation of China (21776203 and (19) Zhang, T.; Wang, L. P.; Bao, Y.; Yang, Q.; Zhou, L. N.; Hao, H.
21576187) and the Natural Science Foundation of Tianjin X.; Xie, C. Confirmation of More Stable Polymorphic Form of
Municipal Science and Technology Commission (No. 18JCY- Etoricoxib at Room Temperature. J. Pharm. Sci. 2018, 107, 1903−
BJC21100). 1910.
■
(20) Jiang, S.; ter Horst, J. H. Crystal Nucleation Rates from
REFERENCES Probability Distributions of Induction Times. Cryst. Growth Des.
2011, 11, 256−261.
(1) Kitamura, M.; Hayashi, Y.; Hara, T. Effect of Solvent and (21) Materials Studio 6.0; Acceryls Inc.: San Diego, CA, 2012.
Molecular Structure on the Crystallization of Polymorphs of BPT (22) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.;
Esters. J. Cryst. Growth 2008, 310, 3067−3071. Robb, M. A.; Cheeseman, J. R.; et al. Gaussian 09, Revision D.01;
(2) Teychené, S.; Biscans, B. Nucleation Kinetics of Polymorphs: Gaussian Inc.: Wallingford, CT, 2009.
Induction Period and Interfacial Energy Measurements. Cryst. Growth
Des. 2008, 8, 1133−1139.
(3) Chen, J.; Trout, B. L. Computational Study of Solvent Effects on
the Molecular Self-Assembly of Tetrolic Acid in Solution and
Implications for the Polymorph Formed from Crystallization. J.
Phys. Chem. B 2008, 112, 7794−7802.
(4) Hamad, S.; Moon, C.; Catlow, C. R. A.; Hulme, A. T.; Price, S.
L. Kinetic Insights into the Role of the Solvent in the Polymorphism
of 5-Fluorouracil from Molecular Dynamics Simulations. J. Phys.
Chem. B 2006, 110, 3323−3329.
(5) Zhang, J. L.; Wu, Y. J.; Liu, A. Y.; Li, W.; Han, Y. Mechanistic
Insight into the Selective Crystallization of the Metastable Polymorph
of Tolbutamide in Ethanol-Water Solution. RSC Adv. 2014, 4,
21599−21607.
(6) Davey, R. J.; Dent, G.; Mughal, R. K.; Parveen, S. Concerning
the Relationship between Structural and Growth Synthons in Crystal
Nucleation: Solution and Crystal Chemistry of Carboxylic Acids As
Revealed through IR Spectroscopy. Cryst. Growth Des. 2006, 6, 1788−
1796.
(7) Khamar, D.; Zeglinski, J.; Mealey, D.; Rasmuson, Å. C.
Investigating the Role of Solvent-Solute Interaction in Crystal
Nucleation of Salicylic Acid from Organic Solvents. J. Am. Chem.
Soc. 2014, 136, 11664−11673.
(8) Yang, H. Y.; Svärd, M.; Zeglinski, J.; Rasmuson, Å. C. Influence
of Solvent and Solid-State Structure on Nucleation of Parabens. Cryst.
Growth Des. 2014, 14, 3890−3902.